Eli Lilly’s new Prozac Fact Sheet (image below) sent to UK physicians–but not to US physicians–states that Prozac is NOT RECOMMENDED FOR CHILDREN for any indication. For a larger view, please click on the image.
AHRP PROPOSAL:
Any FDA-approved drug, whose manufacturer has been found by a court of law or the Department of Justice–to have illegally marketed the drug by concealing risks or incidence of adverse effects, or making unsupported claims of clinical benefit–should be denied coverage by taxpayer funded insurance programs–including Medicaid, Medicare, VeteranstAffairs.
NIH Under Fire: Longtime Favorite of Congress – Wash Post / WSJ Sun, 27 Jun 2004 Under fire from Congress with evidence of NIH staff engaging in secret outside contracts and consultancies, NIH Director, Dr. Elias Zerhouni, turned a corner. He acknowledged the problem at a hearing (June 22) of…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 9, 2002 Debate on Value of ScreeningTests for Cancer FYI Today’s Science section in The New York Timesprovides the kind of critical reporting that has not…
Dr. Carl Elliott's insightful essay in SLATE:: Why do drug companies want to give money to bioethicists in the first place? In the public relations business, this approach is called "third-party strategy."
NY Times Whitewashes Ritalin Experiment in Preschool Kids Sat, 16 Nov 2002 A story in The New York Times magazine about a controversial government sponsored drug experiment avoids examining the tough issues. Instead, it describes the growing pains of an apparently normal 4 year old boy, Sam, whose parents enrolled…
Overshadowing all other health related news, a front page report in The Washington Post and the just released Breckenridge report evaluating FDA's abysmal performance on drug safety, http://ahrp.blogspot.com/2007/03/latest-report-blasts-fda-bungling-drug.html require Congressional action.
